Loretta S. Li

740 total citations
4 papers, 121 citations indexed

About

Loretta S. Li is a scholar working on Molecular Biology, Public Health, Environmental and Occupational Health and Genetics. According to data from OpenAlex, Loretta S. Li has authored 4 papers receiving a total of 121 indexed citations (citations by other indexed papers that have themselves been cited), including 2 papers in Molecular Biology, 2 papers in Public Health, Environmental and Occupational Health and 1 paper in Genetics. Recurrent topics in Loretta S. Li's work include Acute Lymphoblastic Leukemia research (2 papers), Genomics and Chromatin Dynamics (2 papers) and RNA Interference and Gene Delivery (1 paper). Loretta S. Li is often cited by papers focused on Acute Lymphoblastic Leukemia research (2 papers), Genomics and Chromatin Dynamics (2 papers) and RNA Interference and Gene Delivery (1 paper). Loretta S. Li collaborates with scholars based in United States, Germany and Japan. Loretta S. Li's co-authors include Jon C. Aster, Stacey M. Frumm, Haig Inguilizian, Gabriela Alexe, Ilene Galinsky, Richard M. Stone, Giovanni Roti, Versha Banerji, Nicola Tolliday and Kimberly Stegmaier and has published in prestigious journals such as Journal of Clinical Investigation, Blood and Human Genetics.

In The Last Decade

Loretta S. Li

4 papers receiving 120 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Loretta S. Li United States 3 106 35 21 13 13 4 121
Wai-In Chan United Kingdom 5 81 0.8× 53 1.5× 25 1.2× 11 0.8× 8 0.6× 6 135
Elizabeth C. Townsend United States 2 222 2.1× 49 1.4× 29 1.4× 9 0.7× 13 1.0× 3 241
Fabrizio Simeoni United Kingdom 6 145 1.4× 35 1.0× 38 1.8× 8 0.6× 31 2.4× 14 188
Ze Yang United States 6 236 2.2× 19 0.5× 15 0.7× 27 2.1× 21 1.6× 9 259
Anna Skucha Austria 5 136 1.3× 19 0.5× 8 0.4× 9 0.7× 31 2.4× 6 169
Enes Ugur Germany 7 148 1.4× 19 0.5× 13 0.6× 16 1.2× 11 0.8× 11 166
Julien Masliah-Planchon France 2 102 1.0× 14 0.4× 23 1.1× 31 2.4× 12 0.9× 2 124
Gabriel M. C. Longo Germany 5 128 1.2× 15 0.4× 22 1.0× 6 0.5× 14 1.1× 8 156
Konstanze Doehner Germany 4 68 0.6× 41 1.2× 18 0.9× 4 0.3× 12 0.9× 14 101
Courteney K. Lai Germany 6 68 0.6× 50 1.4× 13 0.6× 9 0.7× 14 1.1× 8 104

Countries citing papers authored by Loretta S. Li

Since Specialization
Citations

This map shows the geographic impact of Loretta S. Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Loretta S. Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Loretta S. Li more than expected).

Fields of papers citing papers by Loretta S. Li

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Loretta S. Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Loretta S. Li. The network helps show where Loretta S. Li may publish in the future.

Co-authorship network of co-authors of Loretta S. Li

This figure shows the co-authorship network connecting the top 25 collaborators of Loretta S. Li. A scholar is included among the top collaborators of Loretta S. Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Loretta S. Li. Loretta S. Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

4 of 4 papers shown
1.
Li, Loretta S., Shuo-Chieh Wu, Nadja Kopp, et al.. (2014). Type II JAK2 Inhibitor NVP-CHZ868 Is Active in Vivo Against JAK2-Dependent B-Cell Acute Lymphoblastic Leukemias (B-ALLs). Blood. 124(21). 3713–3713. 1 indexed citations
2.
Banerji, Versha, Stacey M. Frumm, Kenneth N. Ross, et al.. (2012). The intersection of genetic and chemical genomic screens identifies GSK-3α as a target in human acute myeloid leukemia. Journal of Clinical Investigation. 122(3). 935–947. 85 indexed citations
3.
Zhang, Yanming, Nancy J. Zeleznik‐Le, Nimanthi Jayathilaka, et al.. (2004). Characterization of genomic breakpoints in MLL and CBP in leukemia patients with t(11;16). Genes Chromosomes and Cancer. 41(3). 257–265. 22 indexed citations
4.
Smith, Lydia L., Loretta S. Li, Pamela L. Strissel, et al.. (2003). Polymorphisms in the MLL breakpoint cluster region (BCR). Human Genetics. 113(1). 80–91. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026